Can the immune response control HIV infection?

Cell

Volumn 82, Issue 2, 1995, Pages 177-182

  Paul, William E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; INFECTION CONTROL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ATTENUATION;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0029148848     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90304-6     Document Type: Review

References (38)

1. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells
2. Engineering poliovirus as a vaccine vector for the expression of diverse antigens
3. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
4. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
5. Establishment of stable, cell-mediated immunity that makes susceptible mice resistant to Leishmania major
6. Clearance of HIV infection in a perinatally infected infant
7. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
8. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques
9. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy
10. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein
11. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
12. Status and future of Biocine HIV-rgp120SF2 subunit vaccines: the experience of the Biocine Company
13. Superinfection of HIV-1 infected chimpanzees with a second unrelated HIV-1
14. The biochemistry and cell biology of antigen processing and presentation
15. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses
16. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
17. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection
18. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
19. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor
20. + cell antiviral factor
21. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
22. Lymphocyte responses and cytokines
23. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
24. Clinical studies with canarypox vectors containing HIV genes
25. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys
26. Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study
27. Recombination in HIV-1
28. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
29. Extensive variation of human immunodeficiency virus type-1 in vivo
30. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection
31. Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine
32. Isolation and characterization of a syncytium-inducing macrophage/T-cell line tropic HIV-1 isolate that readily infects chimpanzee cells in vitro and in vivo
33. Natural protection against HIV-1 infection provided by HIV-2
34. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization
35. Cytotoxic T-lymphocyte responses to HIV-1 in infected individuals
36. Longterm culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1
37. Viral dynamics in human immunodeficiency virus type 1 infection